PDS Biotech to Participate at Cantor Fitzgerald’s Oncology & HemOnc Conference

September 22, 2022

https://www.globenewswire.com/news-release/2022/09/22/2520953/37149/en/PDS-Biotech-to-Participate-at-Cantor-Fitzgerald-s-Oncology-HemOnc-Conference.html

FLORHAM PARK, N.J., Sept. 22, 2022 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq:PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, today announced that Dr. Frank Bedu-Addo, President and Chief Executive Officer, will participate on a panel at Cantor Fitzgerald’s Oncology & HemOnc Conference being held at the Lotte New York Palace Hotel in New York City on September 28, 2022.

Read more at globenewswire.com

Related news for (PDSB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.